Hyaluronidase-Facilitated Subcutaneous Immunoglobulin 10% as Maintenance Therapy for Japanese Patients with Chronic Inflammatory Demyelinating Polyradiculoneuropathy and Multifocal Motor Neuropathy: A Phase 3, Open-label Clinical Trial
Study Overview The clinical trial investigated the use of hyaluronidase-facilitated subcutaneous immunoglobulin (Ig) 10% as a long-term maintenance therapy for […]
